Scientists Researching Molecule-Blocking Method for Treating Multiple Sclerosis
Multiple sclerosis (MS) is a neurological disease that currently has no cure and no guaranteed treatment. Researchers have worked on developing new, more effective treatments that are less invasive and longer-lasting. New research from the University of Montreal in Canada may have found a new, more advanced treatment fitting those parameters.
The Melanoma Cell Adhesion Molecule (MCAM) allows white blood cells to travel across the blood-brain barrier. This action triggers nerve damage that MS patients suffer. Researchers working on a mouse model of MS learned that blocking this molecule from transporting the white blood cells could delay MS and slow the progression of the disease.
When white blood cells cross the blood-brain barrier they can enter the central nervous system and cause damage that results in MS symptoms such as muscle weakness, loss of vision, and disruption of motor skills. By identifying the molecule that facilitates transport of the white blood cells, researchers can block the damage before it happens.
MS progresses differently in each person, and while one patient may live a lifetime with only minor symptoms, others may spend their lives requiring assistance and medical device support. If researchers are successful in developing this new treatment method for use in humans, they believe it could result in up to a 50 percent reduction in MS symptoms, as seen in the mouse models.
For some disabling conditions, improving quality of life is the only thing current medical science can do to help patients. If you or a loved one suffer from multiple sclerosis and can no longer work or earn a substantial income, Disability Help Group can help. Call today – 1-(800)-800-3332.